BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension
Shilpa Johri, CLAIRE THRASHER, Leslie Spikes, Harold I. Palevsky et al.
Citations
3 citations
Journal
Respiratory Medicine
Topics
Pulmonary Hypertension Research and Treatments
Field-Weighted Citation Impact (FWCI)
4.56
article
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension
Shilpa Johri, CLAIRE THRASHER, Leslie Spikes, Harold I. Palevsky, Charles D. Burger, C. Q. Deng, Shelley Shapiro, Trushil Shah, Abubakr Bajwa, Micah R. Fisher, Peter Smith, Sandeep Sahay, Meredith Broderick, Ricardo Restrepo‐Jaramillo, Michael Eggert, Karim El‐Kersh, Gautam Ramani, Joanna M. Joly, Sapna Desai, J.P. Mehta
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Respiratory MedicineVol. 248
Institutions
University of Maryland, Baltimore (US), Emory Healthcare (US), University of Arizona (US), Emory University (US), University of South Florida (US), Ochsner Medical Center (US), Jacksonville College (US), Tampa General Hospital (US), University of Alabama at Birmingham (US), Cleveland Clinic Florida (US), Methodist Hospital (US), Sentara Heart Hospital (US), University of Kansas Medical Center (US), United Therapeutics (United States) (US), Pulmonary Associates (US), Mayo Clinic in Florida (US), VA Greater Los Angeles Healthcare System (US), Pulmonary and Critical Care Associates (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US), University of Tampa (US)